Navigation Links
iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
Date:6/19/2008

NASHUA, N.H., June 19 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced it has initiated a clinical study for Colon CAD, its virtual colonoscopy CAD product, in partnership with ACR Image Metrix, a subsidiary of the American College of Radiology (ACR). iCAD and ACR Image Metrix, having completed the development portion of the study, are collaborating on study execution including a multi- reader, multi-case (MRMC) clinical study designed to assess the impact of Colon CAD on the accuracy of interpreting CT Colonography exams also known as virtual colonoscopies. The study will also assess the sensitivity of Colon CAD for detecting polyps and will measure the impact of iCAD's CT Colon CAD product on interpretation and workflow.

Virtual colonoscopy offers patients a less invasive option to conventional colonic polyp detection techniques. Reviewing these images can be tedious and challenging because of the amount of information captured in a CT exam. iCAD's colon CAD product uses sophisticated image processing analysis technology to identify polyps in images with the potential for streamlining the reading process and improving accuracy, productivity and workflow. The study, which will be managed and executed by ACR Image Metrix, will include up to 20 radiologists, is expected to take about six months to complete and will include the analysis of several hundred cases tested with virtual colonoscopy featuring Colon CAD.

"Moving to this clinical study, which should enable iCAD to submit the necessary data to the FDA, is an exciting step bringing the Company closer to taking our Colon CAD product to market," said Ken Ferry, President and Chief Executive Officer of iCAD. "Working with ACR Image Metrix, a group with a high level of expertise in this area, will be of great value in helping us prove the tremendous benefits we bel
'/>"/>

SOURCE iCAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
2. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
5. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
6. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
7. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
8. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
9. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
10. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
11. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 1Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 2Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 1National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 2National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 4National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 5Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 1Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 2Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 3Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 4Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 5